Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01458067
Title A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

Advanced Solid Tumor

Therapies

GSK2636771

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site New Haven Connecticut 06520 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Seoul 110-744 Korea, Republic of Details
GSK Investigational Site Seoul 120/752 Korea, Republic of Details
GSK Investigational Site Sutton Surrey SM2 5PT United Kingdom Details
GSK Investigational Site London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field